Skip to content

MIRA

MIRA Pharmaceuticals, Inc.

NASDAQ · Healthcare · Drug Manufacturers - General · US

$0.76
+3.27%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-23.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 15, 2026Del Giudice Matthew Paul · directorA-Award50,000$0.94
Jun 15, 2026Whalen Matthew Pratt · directorA-Award50,000$0.94
Jun 15, 2026Shekhat Denil Nanji · directorA-Award50,000$0.94
Jun 15, 2026MacPherson Edward Clouston · directorA-Award50,000$0.94
Apr 1, 2026Aminov Erez · director, officer: Chief Executive OfficerA-Award83,500$0.00
Feb 17, 2026Aminov Erez · director, officer: CEO and ChairmanA-Award3,155,170$1.45
Feb 17, 2026Aminov Erez · director, officer: CEO and ChairmanM-Exempt379,000$0.84
Feb 17, 2026Aminov Erez · director, officer: CEO and ChairmanM-Exempt234,595$1.16
Oct 3, 2025Shekhat Denil Nanji · directorA-Award22,378$1.35
Oct 3, 2025Aminov Erez · director, officer: Chief Executive OfficerA-Award2,685,456$0.00
Sep 18, 2025Aminov Erez · director, officer: Chief Executive OfficerA-Award150,000$1.38
Sep 3, 2025Aminov Erez · director, officer: Chief Executive OfficerA-Award62,500$1.37
Dec 10, 2024Shekhat Denil Nanji · directorA-Award50,000$1.19
Dec 10, 2024Del Giudice Matthew Paul · directorA-Award25,000$1.19
Dec 10, 2024MacPherson Edward Clouston · directorA-Award25,000$1.19
Dec 10, 2024Yanez Michelle · officer: Chief Financial OfficerA-Award150,000$1.19
Dec 10, 2024Aminov Erez · director, officer: Chief Executive OfficerA-Award2,000,000$1.19
Dec 10, 2024Aminov Erez · director, officer: Chief Executive OfficerA-Award500,000$0.00
Dec 10, 2024Whalen Matthew Pratt · directorA-Award25,000$1.19
Nov 27, 2024Aminov Erez · director, officer: Chief Executive OfficerSale44,590$1.27
Nov 27, 2024Aminov Erez · director, officer: Chief Executive OfficerSale55,410$1.39
Aug 30, 2024McNulty Brian Patrick · 10 percent ownerSale200,000$1.96
Jun 21, 2024Shekhat Denil Nanji · directorA-Award50,000$0.71
May 30, 2024Aminov Erez · director, officer: Chief Executive OfficerA-Award379,000$0.84
May 22, 2024Aminov Erez · director, officer: Chief Executive OfficerPurchase800$0.97
May 22, 2024Aminov Erez · director, officer: Chief Executive OfficerPurchase600$0.87
May 22, 2024Aminov Erez · director, officer: Chief Executive OfficerPurchase1,000$0.85
May 22, 2024Aminov Erez · director, officer: Chief Executive OfficerPurchase2,000$0.84
May 22, 2024Aminov Erez · director, officer: Chief Executive OfficerPurchase500$1.02
Mar 27, 2024Del Giudice Matthew Paul · directorA-Award50,000$1.16
Institutional positioning

13F filings over the trailing two quarters

New 8Increased 6Reduced 1Sold out 26
FilerActionSharesFiled
VANGUARD CAPITAL MANAGEMENT LLCNew Position693,912May 15, 2026
CROSS STAFF INVESTMENTS INCUnchanged359,401Apr 23, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased290,890May 15, 2026
VANGUARD FIDUCIARY TRUST CONew Position169,483May 8, 2026
BLACKROCK, INC.Increased112,346May 13, 2026
SUNCOAST EQUITY MANAGEMENTReduced90,645May 8, 2026
NORTHERN TRUST CORPUnchanged67,698May 14, 2026
FIRST AMERICAN BANKUnchanged60,000Apr 20, 2026
STATE STREET CORPUnchanged49,100May 15, 2026
XTX TOPCO LTDIncreased37,573May 15, 2026
COMMONWEALTH EQUITY SERVICES, LLCIncreased35,067Apr 27, 2026
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLCUnchanged35,000May 1, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPNew Position25,146May 15, 2026
VANGUARD GLOBAL ADVISERS, LLCNew Position24,306May 8, 2026
Frec Markets, Inc.New Position22,000May 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 15, 2026